The Net Margin of Ocumension Therapeutics (1477.HK) is -19.75%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -19.75% |
| 2024-12-31 | -64.29% |
| 2023-12-31 | -154.15% |
| 2022-12-31 | -253.30% |
| 2021-12-31 | -463.06% |
| 2020-12-31 | -17294.33% |
| 2019-12-31 | -690690.00% |
| 2018-12-31 | -690690.00% |